BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 29142248)

  • 1. The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.
    Pfaff CM; Marquardt Y; Fietkau K; Baron JM; Lüscher B
    Sci Rep; 2017 Nov; 7(1):15631. PubMed ID: 29142248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
    Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
    Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis.
    Varshney P; Narasimhan A; Mittal S; Malik G; Sardana K; Saini N
    Sci Rep; 2016 Jan; 6():19295. PubMed ID: 26781963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
    Varshney P; Saini N
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A and Keratinocytes in Psoriasis.
    Furue M; Furue K; Tsuji G; Nakahara T
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes.
    Muromoto R; Hirao T; Tawa K; Hirashima K; Kon S; Kitai Y; Matsuda T
    Int Immunol; 2016 Sep; 28(9):443-52. PubMed ID: 26944069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
    Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
    Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.
    Wang W; Yu X; Wu C; Jin H
    Int J Med Sci; 2017; 14(10):1002-1007. PubMed ID: 28924372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
    Xu X; Prens E; Florencia E; Leenen P; Boon L; Asmawidjaja P; Mus AM; Lubberts E
    Front Immunol; 2021; 12():719562. PubMed ID: 34616394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation.
    Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N
    Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
    Johnston A; Fritz Y; Dawes SM; Diaconu D; Al-Attar PM; Guzman AM; Chen CS; Fu W; Gudjonsson JE; McCormick TS; Ward NL
    J Immunol; 2013 Mar; 190(5):2252-62. PubMed ID: 23359500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis.
    Chen HL; Lo CH; Huang CC; Lu MP; Hu PY; Chen CS; Chueh DY; Chen P; Lin TN; Lo YH; Hsiao YP; Hsu DK; Liu FT
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33055419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.
    Carrier Y; Ma HL; Ramon HE; Napierata L; Small C; O'Toole M; Young DA; Fouser LA; Nickerson-Nutter C; Collins M; Dunussi-Joannopoulos K; Medley QG
    J Invest Dermatol; 2011 Dec; 131(12):2428-37. PubMed ID: 21881584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes.
    Ehst B; Wang Z; Leitenberger J; McClanahan D; De La Torre R; Sawka E; Ortega-Loayza AG; Strunck J; Greiling T; Simpson E; Liu Y
    Cytokine; 2021 Feb; 138():155357. PubMed ID: 33153894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.